Dupont Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,426
| Closed | -$276K | – | 1816 |
|
|
2021
Q1 | $276K | Sell |
2,426
-498
| -17% | -$56.7K | 0.01% | 1175 |
|
|
2020
Q4 | $405K | Sell |
2,924
-219
| -7% | -$30.3K | 0.01% | 922 |
|
|
2020
Q3 | $258K | Buy |
+3,143
| New | +$258K | 0.01% | 1029 |
|
|
2016
Q2 | – | Sell |
-7,292
| Closed | -$462K | – | 701 |
|
|
2016
Q1 | $462K | Hold |
7,292
| – | – | 0.01% | 556 |
|
|
2015
Q4 | $818K | Buy |
+7,292
| New | +$818K | 0.02% | 507 |
|